The product of the blr1 gene is a CXC chemokine receptor (CXCR5) that regulates B lymphocyte migration and has been implicated in myelomonocytic differentiation. The U937 human leukemia cell line was used to study the role of blr1 in retinoic acid-regulated monocytic leukemia cell growth and differentiation. blr1 mRNA expression was induced within 12 hr by retinoic acid in U937 cells. To determine whether the early induction of blr1 might regulate inducible monocytic cell differentiation, U937 cells were stably transfected with blr1 (U937/blr1 cells). Ectopic expression of blr1 caused no significant cell cycle or differentiation changes, but caused the U937/blr1 cells to differentiate faster when treated with either retinoic acid or 1α,5-dihydroxyvitamin D3. Treated with retinoic acid, U937/blr1 cells showed a greater increase in the percentage of CD11b expressing cells than vector control cells. Retinoic acid also Induced a higher percentage of functionally differentiated blr1 transfectants as assessed by nitroblue tetrazolium reduction. U937/blr1 cells underwent moderate growth inhibition on treatment with retinoic acid. Similar results occurred with 1α,25-dihydroxyvitamin D3. Because blr1 was induced early during cell differentiation and because its overexpression accelerated monocytic differentiation, it may be Important for signals controlling cell differentiation.
Get full access to this article
View all access options for this article.
References
1.
MehtaK, Lopex-BeresteinG. Expression of tissue transglutaminase in cultured monocytic leukemia (THP-1) cells during differentiation. Cancer Res46: 13881394, 1986.
2.
BreitmanT, KeeneB, HemmiH. Retinoic acid-induced differentiation of fresh human leukaemia cells and the human myelomonocytic leukaemia cell lines, HL-60, U-937, and THP-1. Cancer Surveys2: 261291, 1983.
3.
OlssonIL, BreitmanTR. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3: 5-monophosphate -inducing agents. Cancer Res42: 39243927, 1982.
4.
LanotteM, Martin-ThouveninV, NajmanS, BaleriniP, ValensiF, BergerR. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood77: 10801086, 1991.
5.
HuangME, YeYC, ChenSR, ChaiJR, LuJX, ZhoaL, GuLJ, WangZY. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood72: 567572, 1988.
6.
CraigR, FrankfurtO, SakagamiH, TakedaK, BlochA. Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells. Cancer Res44: 24212429, 1984.
7.
BreitmanTR, SelonickSE, CollinsSJ. Induction of differentiation of human promyelocytic leukemia cells (HL-60) by retinoic acid. Proc Natl Acad Sci USA77: 29362940, 1980.
8.
MangelsdorfDJ, KazukikoU, EvansRM. The retinoid receptors. In: SpornMB, RobertsA, GoodmanDS, Eds. The Retinoids (2nd ed.). New York: Raven Press, pp 319349, 1994.
DobnerT, WolfI, EmrichT, LippM. Differentiation-specific expression of a novel G protein-coupled receptor from Burkitt's lymphoma. Eur J Immunol22: 27952799, 1992.
11.
GunnMD, NgoVN, AnselKM, EklandEH, CysterJG, WilliamsLT. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature391: 799803, 1998.
12.
LeglerDF, LoetscherM, RoosRS, Clark-LewisI, BaggioliniM, MoserB. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med187: 655660, 1998.
13.
FörsterR, MattisAE, KremmerE, WolfE, BremG, LippM. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell87: 10371047, 1996.
14.
BarellaL, LoetshcerM, ToblerA, BaggioliniM, MoserB. Sequence variation of a novel heptahelical leukocyte receptor through alternative transcript formation. Biochem J309: 773779, 1995.
15.
YenA, RobersonMS, VarvayanisS, LeeAT. Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res58: 31633172, 1998.
16.
ChaoJR, ChenCS, WangTF, TsengLH, TsaiJJ, KuoML, YenJJY, YenHFY. Characterization of factor-independent variants derived from TF-1 hematopoietic progenitor cells: The role of the Raf/MAP kinase pathway in the anti-apoptotic effect of GM-CSF. Oncogene14: 721728, 1997.
17.
WhalenAM, GalakinskiSC, ShapiroPS, NahreiniTS, AhnNG. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Mol Cell Biol17: 19471958, 1997.
18.
MaherJ, BakerD, DibbN, RobertsI. Mutant ras promotes haemopoietic cell proliferation or differentiation in a cell-specific manner. Leuk10: 8390, 1996.
19.
WangHG, MiyashitaT, TakayamaS, SatoT, TorigoeT, KrajewskiS, TanakaS, HoveyLI, TroppmairJ, RappUR, ReedJC. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene9: 27512756, 1994.
20.
YenA, WilliamsM, PlatkoJD, DerC, HisakaM. Expression of activated RAF accelerates cell differentiation and RB protein down-regulation but not hypophosphorylation. Eur J Cell Biol65: 103113, 1994.
21.
RaggSJ, KagaS, BergKA, OchiA. The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937. J Immunol161: 13901398, 1998.
22.
FranklinCC, KraftAS. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells. Oncogene11: 23652374, 1995.
23.
YenA, SturgillR, VarvayanisS. Increasing c-FMS expression decreases retinoic acid concentration needed to cause cell differentiation and RB hypophosphorylation. Cancer Res57: 20202028, 1997.
24.
YenA, SturgillR, VarvayanisS. Retinoic acid increases amount of phosphorylated RAF; ectopic expression of cFMS reveals that retinoic acid induced differentiation is more strongly dependent on ERK2 signaling than induced GO arrest is. In Vitro Cell Dev Biol Anim36: 249255, 2000.
25.
JhoEH, MalbonCC. Gα12 and Gα13 mediate differentiation of P19 mouse embryonal carcinoma cells in response to retinoic acid. J Biol Chem272: 2446124467, 1997.
26.
MeissnerJD, BrownGA, MuellerWH, SchueibeRJ. Retinoic acid-mediated decrease of Gαs protein expression: involvement of Gαs in the differentiation of HL-60 myeloid cells. Exp Cell Res225: 112121, 1996.
27.
IshiguroS, TakahashiN, NemotoK, NegishiM, IchikawaA. Potentiation of retinoic acid-induced differentiation of HL-60 cells by prostaglandin EP2 receptor. Prostaglandins Other Lipid Mediat56: 145153, 1998.
28.
WatkinsDC, JohnsonGL, MalbonCC. Regulation of the differentiation of teratocarcinoma cells into primitive endoderm by Gα12. Science258: 13731375, 1992.
